Moreover, bladder cancer cells with BCCE4[G] overexpression might exhibit a better response to anti‐PD‐L1 treatment in vitro; however, further validation based on a population study and in vivo models is necessary. The gene discussed is CD274; the disease is urinary bladder carcinoma.